None
Quote | TCR2 Therapeutics Inc. (NYSE:TCRR)
Last: | $ |
---|---|
Change Percent: | -0.93% |
Open: | $14.00 |
Close: | $13.81 |
High: | $14.114 |
Low: | $13.3186 |
Volume: | 57,677 |
Last Trade Date Time: | 02/12/2020 04:39:55 pm |
News | TCR2 Therapeutics Inc. (NYSE:TCRR)
2023-06-01 17:02:47 ET Adaptimmune ( NASDAQ: ADAP ) said that it has completed its planned merger with fellow T-cell therapy developer TCR2 ( TCRR ). The immunology companies announced the merger in March. After the closing Adaptimmune shareholders own around 75% of the comb...
2023-05-11 07:52:15 ET TCR2 Therapeutics press release ( NASDAQ: TCRR ): Q1 GAAP EPS of -$1.03 misses by $0.34 . TCR 2 ended the first quarter of 2023 with $110.3 million in cash, cash equivalents, and investments compared to $149.2 million as of December 31, 2022....
Message Board Posts | TCR2 Therapeutics Inc. (NYSE:TCRR)
Subject | By | Source | When |
---|---|---|---|
$TCRR GET READY TO RUMBLE | TrendTrade2016 | investorshub | 03/06/2023 4:34:28 PM |
Decent pipeline they have here | harry crumb | investorshub | 03/06/2023 12:49:25 PM |
Adaptimmune and TCR Therapeutics Announce Strategic Combination to | subslover | investorshub | 03/06/2023 12:23:26 PM |
A PR from earlier in the month https://www.globenewswire.com/news-release/2021/1 | jondoeuk | investorshub | 10/20/2021 7:21:12 PM |
Webcast https://onlinexperiences.com/scripts/Server.nxp?LASCmd=AI%3A4%3BF%3AQS%2 | jondoeuk | investorshub | 10/20/2021 7:18:13 PM |
News, Short Squeeze, Breakout and More Instantly...
TCR2 Therapeutics Inc. Company Name:
TCRR Stock Symbol:
NYSE Market:
TCR2 Therapeutics Inc. Website:
CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR) (TCR 2 or the Company), a clinical-stage cell therapy company with a pipeline of novel next-generation T cell therapies for patients suffering from solid tumors, today announced financial results for...
NEW YORK, NY / ACCESSWIRE / April 13, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Univar Solutions Inc. (NYSE:UNVR)'s ...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Radius Global Infrastructure, Inc....